New hope: drug shields stem cell patients from deadly fungal lung infections
NCT ID NCT04725942
First seen Feb 18, 2026 · Last updated May 13, 2026 · Updated 12 times
Summary
This study tested whether posaconazole tablets can prevent lung fungal infections in 360 patients who had a stem cell transplant. Researchers measured drug levels in the blood and checked for infections. The goal was to find the right dose to keep patients safe from these serious infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY FUNGAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, China
-
Shanxi Bethune Hospital
Taiyuan, China
-
The Second Hospital of Hebei Medical University
Shijia Zhuang, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Conditions
Explore the condition pages connected to this study.